From the Journals
From the Journals
Early-life antibiotic use may raise risk of early-onset CRC
"Individuals with genetic risk factors (i.e., family history of CRC) who have experienced early-life antibiotics use on a long-term basis are...
From the Journals
Autoantibodies could help predict cancer risk in scleroderma
The autoantibodies anti-POLR3 and monospecific anti-Ro52 were associated with increased cancer risk, while anti-centromere and anti-U1RNP were...
From the Journals
AI-supported breast screens may reduce radiologist workload
The potential for overdiagnosis or overdetection of indolent lesions in the intervention group should “prompt caution in the interpretation of...
From the Journals
Cancer diagnoses, care access rise after Medicaid expansion
In Ohio, researchers found a substantial increase in diagnoses for all three cancers among Medicaid patients after expansion.
From the Journals
Neutropenia affects clinical presentation of pulmonary mucormycosis
Bronchoalveolar lavage was s stronger contributor to diagnosis in nonneutropenic patients.
Latest News
Fatalities from breast cancer have ‘improved substantially’
Women diagnosed with early-stage breast cancer are more likely to become long-term survivors of the disease now than they were 20 years ago.
From the Journals
RFS failed as endpoint in adjuvant immunotherapy trials
“Our meta-analysis failed to find a significantly strong association between RFS and OS in RCTs of adjuvant immunotherapy,” the authors concluded...
From the Journals
DCIS isn’t an automatic indication for mastectomy in HER2+ BC
In the largest look into the issue to date, investigators find that neoadjuvant therapy clears DCIS about half of the time.
From the Journals
Short bursts of activity may cut cancer risk
Examples of such activity are vigorous housework, carrying heavy shopping bags around the grocery store, bursts of power walking, and playing high...
From the Journals
Survival, QoL trump PFS for most patients with cancer
“The results of our study demonstrate that more than half of patients with advanced cancer would not want a treatment that delays time to...
From the Journals
Anticoagulants for cancer-related VTE: What works best?
These data may “help facilitate shared decision-marking and inform clinical guidelines for the treatment of such patients.”